Articles

Journal of Endovascular Therapy Hypertension Renal Denervation Therapy

Patients with hypertension after renal artery stenting who do not respond to drug treatment may have another option. 

St. Jude Medical Portico TAVR System U.S. Implants Clinical Study

St. Jude Medical Inc. announced that the first patient implants occurred in the Portico Re-sheathable Transcatheter Aortic Valve System U.S. IDE Trial (PORTICO trial).

May 19, 2014 — A new study found that adding an electrocardiogram (ECG) to existing pre-participation screening of high school athletes increases the likelihood of identifying disorders associated...

May 19, 2014 — St. Jude Medical announced that data presented during a late-breaking clinical trial session at the 2014 annual scientific sessions of the Heart Rhythm Society (HRS) found an...

Cardiac Diagnostics Clinical Trial Journal of Experimental Medicine

A study in The Journal of Experimental Medicine shows that IκB kinase β (IKKβ) functions in smooth muscle cells to regulate vascular inflammatory responses and atherosclerosis...

Boston Scientific Corp. ICD HRS 35th Annual Scientific Sessions SIMPLE Trial

A Boston Scientific Corp. study demonstrated that outcomes for patients with the company's transvenous implantable cardioverter defibrillators (ICD) who received routine defibrillation testing (DT...

May 12, 2014 — Patients using the Boston Scientific Latitude remote patient management system with wireless telemetry demonstrated significantly lower mortality and fewer hospitalizations...

E-health Mobile Devices Apps Cardiac Diagnostics Australia Cardiology Monitoring

Studies presented at the World Heart Federation’s World Congress of Cardiology on May 5, 2014 showcased new research on best practices in the design and development of healthcare mobile...

It is impossible to escape the reality that as the use of mobile electronic devices increases amongst consumers, a proportionate increase in the use of such devices in the medical sales and...

Cytori Stem Cell Therapy Heart Failure Treatments PRECISE Trial

Cytori Therapeutics announced publication of safety and efficacy data from a 36 month European clinical trial of Cytori Cell Therapy in patients with chronic ischemic heart failure.